Literature DB >> 24861339

Risk of birth defects associated with maternal pregestational diabetes.

Marco Vinceti1, Carlotta Malagoli, Kenneth J Rothman, Rossella Rodolfi, Gianni Astolfi, Elisa Calzolari, Aurora Puccini, Marco Bertolotti, Mark Lunt, Luisa Paterlini, Mariella Martini, Fausto Nicolini.   

Abstract

Maternal diabetes preceding pregnancy may increase the risk of birth defects in the offspring, but not all studies confirm this association, which has shown considerable variation over time, and the effect of having type 1 versus type 2 diabetes is unclear. We conducted a population-based cohort study in the Northern Italy Emilia-Romagna region linking administrative databases with a Birth Defects Registry. From hospital discharge records we identified all diabetic pregnancies during 1997-2010, and a population of non-diabetic parturients matched for age, residence, year and delivery hospital. We collected available information on education, smoking and drug prescriptions, from which we inferred the type of diabetes. We found 62 malformed infants out of 2,269 births among diabetic women, and 162 out of 10,648 births among non-diabetic women. The age-standardized prevalence ratio (PR) of malformation associated with maternal pregestational diabetes was 1.79 (95 % confidence interval 1.34-2.39), a value that varied little by age. Type of diabetes strongly influenced the PR, with higher values related to type 2 diabetic women. Most major subgroups of anomalies had PRs above 1, including cardiovascular, genitourinary, musculoskeletal, and chromosomal abnormalities. There was an unusually high PR for the rare defect 'extra-ribs', but it was based on only two cases. This study indicates that maternal pregestational type 2 diabetes is associated with a higher prevalence of specific birth defects in offspring, whereas for type 1 diabetic mothers, particularly in recent years, the association was unremarkable.

Entities:  

Mesh:

Year:  2014        PMID: 24861339     DOI: 10.1007/s10654-014-9913-4

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  67 in total

1.  Pregestational diabetes and pregnancy: an Australian experience.

Authors:  Aidan McElduff; Glynis P Ross; Janet A Lagström; Bernard Champion; Jeff R Flack; Sue-Mei Lau; Robert G Moses; Sivanthi Seneratne; Mark McLean; N Wah Cheung
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

2.  Prepregnancy care and pregnancy outcomes in women with type 1 diabetes.

Authors:  Rosemary C Temple; Vivien J Aldridge; Helen R Murphy
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

3.  ATLANTIC-DIP: raised maternal body mass index (BMI) adversely affects maternal and fetal outcomes in glucose-tolerant women according to International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria.

Authors:  Michael Conall Dennedy; Gloria Avalos; Michael W O'Reilly; Eoin P O'Sullivan; Geraldine Gaffney; Fidelma Dunne
Journal:  J Clin Endocrinol Metab       Date:  2012-02-08       Impact factor: 5.958

4.  Maternal pre-pregnancy body mass index and risk of selected birth defects: evidence of a dose-response relationship.

Authors:  Suzanne R Block; Sharon M Watkins; Jason L Salemi; Rachel Rutkowski; Jean Paul Tanner; Jane A Correia; Russell S Kirby
Journal:  Paediatr Perinat Epidemiol       Date:  2013-10-10       Impact factor: 3.980

5.  Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes.

Authors:  A Aberg; L Westbom; B Källén
Journal:  Early Hum Dev       Date:  2001-03       Impact factor: 2.079

Review 6.  Understanding diabetic teratogenesis: where are we now and where are we going?

Authors:  Sheller Zabihi; Mary R Loeken
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-10

7.  Fetal and maternal outcomes in Indo-Asian compared to caucasian women with diabetes in pregnancy.

Authors:  F P Dunne; P A Brydon; M Proffitt; T Smith; H Gee; R L Holder
Journal:  QJM       Date:  2000-12

8.  Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes.

Authors:  Andrea Guerin; Rosane Nisenbaum; Joel G Ray
Journal:  Diabetes Care       Date:  2007-04-19       Impact factor: 19.112

9.  Impact of prenatal risk factors on congenital heart disease in the current era.

Authors:  Alan Fung; Cedric Manlhiot; Sapna Naik; Herschel Rosenberg; John Smythe; Jane Lougheed; Tapas Mondal; David Chitayat; Brian W McCrindle; Seema Mital
Journal:  J Am Heart Assoc       Date:  2013-05-31       Impact factor: 5.501

10.  Adverse pregnancy outcomes in women with diabetes.

Authors:  Carlos Antonio Negrato; Rosiane Mattar; Marilia B Gomes
Journal:  Diabetol Metab Syndr       Date:  2012-09-11       Impact factor: 3.320

View more
  13 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  Does maternal exposure to benzene and PM10 during pregnancy increase the risk of congenital anomalies? A population-based case-control study.

Authors:  Marco Vinceti; Carlotta Malagoli; Marcella Malavolti; Andrea Cherubini; Giuseppe Maffeis; Rossella Rodolfi; Julia E Heck; Gianni Astolfi; Elisa Calzolari; Fausto Nicolini
Journal:  Sci Total Environ       Date:  2015-09-26       Impact factor: 7.963

3.  GESTATIONAL DIABETES MELLITUS AND THE DEVELOPMENT OF CLEFT LIP / PALATE IN NEWBORNS.

Authors:  A Kozma; V Radoi; R Ursu; C L Bohaltea; H Lazarescu; S Carniciu
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jan-Mar       Impact factor: 0.877

4.  The effect of maternal diabetes on the Wnt-PCP pathway during embryogenesis as reflected in the developing mouse eye.

Authors:  Beatriz López-Escobar; David A Cano; Anabel Rojas; Beatriz de Felipe; Francisco Palma; José A Sánchez-Alcázar; Deborah Henderson; Patricia Ybot-González
Journal:  Dis Model Mech       Date:  2014-12-24       Impact factor: 5.758

5.  Congenital anomalies in children exposed to antithyroid drugs in-utero: a meta-analysis of cohort studies.

Authors:  Huixia Li; Jianfei Zheng; Jiayou Luo; Rong Zeng; Na Feng; Na Zhu; Qi Feng
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

6.  A Systematic Review and Meta-Analysis of Diabetes During Pregnancy and Congenital Genitourinary Abnormalities.

Authors:  Mounika Parimi; Dorothea Nitsch
Journal:  Kidney Int Rep       Date:  2020-02-28

Review 7.  The status of diabetic embryopathy.

Authors:  Ulf J Eriksson; Parri Wentzel
Journal:  Ups J Med Sci       Date:  2016-04-27       Impact factor: 2.384

Review 8.  Obstetric and offspring risks of women's morbid conditions linked to prior anticancer treatments.

Authors:  Juan J Tarín; Miguel A García-Pérez; Antonio Cano
Journal:  Reprod Biol Endocrinol       Date:  2016-07-07       Impact factor: 5.211

9.  Insulin analogues use in pregnancy among women with pregestational diabetes mellitus and risk of congenital anomaly: a retrospective population-based cohort study.

Authors:  Hao Wang; Ewa Wender-Ozegowska; Ester Garne; Margery Morgan; Maria Loane; Joan K Morris; Marian K Bakker; Miriam Gatt; Hermien de Walle; Susan Jordan; Anna Materna-Kiryluk; Vera Nelen; Guy Thys; Awi Wiesel; Helen Dolk; Lolkje T W de Jong-van den Berg
Journal:  BMJ Open       Date:  2018-02-24       Impact factor: 2.692

10.  A comparison of the anti-diabetic potential of d-ribose-l-cysteine with insulin, and oral hypoglycaemic agents on pregnant rats.

Authors:  Abraham A A Osinubi; Leke Jacob Medubi; Edidiong N Akang; Lawal K Sodiq; Titilola A Samuel; Taiwo Kusemiju; James Osolu; Danladi Madu; Olufemi Fasanmade
Journal:  Toxicol Rep       Date:  2018-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.